Brain natriuretic peptide-guided management of chronic heart failure: first do no harm

scientific article published on 2 July 2013

Brain natriuretic peptide-guided management of chronic heart failure: first do no harm is …
instance of (P31):
scholarly articleQ13442814
editorialQ871232

External links are
P356DOI10.1093/EURJHF/HFT109
P698PubMed publication ID23821462
P5875ResearchGate publication ID244992641

P50authorMark RichardsQ105243769
P2860cites workThe EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatmentQ28195357
Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trialsQ34614873
Drug treatment of chronic heart failure in the elderlyQ37004476
Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trialsQ37584696
A review of heart failure management in the elderly populationQ37641481
Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary careQ37762320
BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trialQ38383948
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trialQ43549494
Association between performance measures and clinical outcomes for patients hospitalized with heart failureQ46531768
B-type natriuretic peptide-guided heart failure therapy: A meta-analysisQ48263615
Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunctionQ48563810
Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.Q50999983
Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT‐proBNP Guided Management of Heart Failure – SIGNAL‐HF (Swedish Intervention study – Guidelines and NT‐proBNP AnaLysis in Heart Failure)Q51654594
P433issue8
P921main subjectchronic heart failureQ11829287
brain natriuretic peptideQ66360952
P304page(s)832-834
P577publication date2013-07-02
P1433published inEuropean Journal of Heart FailureQ5017954
P1476titleBrain natriuretic peptide-guided management of chronic heart failure: first do no harm
P478volume15

Reverse relations

Q35145230Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophycites workP2860

Search more.